Macrophage-induced adipose tissue dysfunction and the preadipocyte: Should I stay (and differentiate) or should I go?

Advances in Nutrition

Volumn 4, Issue 1, 2013, Pages 67-75

  Sorisky, Alexander ^a   Molgat, André S D ^a   Gagnon, AnneMarie ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; ANIMAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; HUMAN; HYPERPLASIA; HYPERTROPHY; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE; METABOLISM; MOUSE; OBESITY; PATHOPHYSIOLOGY; REVIEW;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; HYPERPLASIA; HYPERTROPHY; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGES; MICE; MODELS, ANIMAL; OBESITY;

MLCS; MLOWN;

EID: 84879432497     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.112.003020     Document Type: Review

References (96)

1. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012;18:363-74.
2. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094-101.
3. Cawthorn WP, Scheller EL, MacDougald OA. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J Lipid Res. 2012;53:227-46.
4. Hirsch J, Fried SK, Edens NK, Leibel RL. The fat cell. Med Clin North Am. 1989;73:83-96.
5. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature. 2008;453:783-7.
6. 2O. Am J Physiol Endocrinol Metab. 2004;286:E577-88.
7. Tchoukalova YD, Votruba SB, Tchkonia T, Giorgadze N, Kirkland JL, Jensen MD. Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci U S A. 2010;107:18226-31.
8. Arner E, Westermark PO, Spalding KL, Britton T, Rydén M, Frisén J, Bernard S, Arner P. Adipocyte turnover: relevance to human adipose tissue morphology. Diabetes. 2010;59:105-9.
9. Oñate B, Vilahur G, Ferrer-Lorente R, Ybarra J, Díez-Caballero A, Ballesta-López C, Moscatiello F, Herrero J, Badimon L. The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients. FASEB J. 2012;26:4327-36.
10. Tchoukalova Y, Koutsari C, Jensen M. Committed subcutaneous preadipocytes are reduced in human obesity. Diabetologia. 2007;50:151-7.
11. Permana PA, Nair S, Lee Y-H, Luczy-Bachman G, Vozarova de Courten B, Tataranni PA. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. Am J Physiol Endocrinol Metab. 2004;286:E958-62.
12. Kursawe R, Eszlinger M, Narayan D, Liu T, Bazuine M, Cali AM, D'Adamo E, Shaw M, Pierpont B, Shulman GI, et al. Cellularity and adipogenic profile of the abdominal subcutaneous adipose tissue from obese adolescents: association with insulin resistance and hepatic steatosis. Diabetes. 2010;59:2288-96.
13. Sepe A, Tchkonia T, Thomou T, Zamboni M, Kirkland JL. Aging and regional differences in fat cell progenitors - a mini-review. Gerontology. 2011;57:66-75.
14. Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR. Insulin-sensitive obesity in humans - a 'favorable fat' phenotype? Trends Endocrinol Metab. 2012;23:116-24.
15. Danforth E Jr. Failure of adipocyte differentiation causes type 2 diabetes mellitus? Nat Genet. 2000;26:13.
16. Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type 2 diabetes mellitus. Int J Obes. 2004;28: S12-21.
17. Dalmas E, Clément K, Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol. 2011;32:307-14.
18. Van Harmelen V, Skurk T, Hauner H. Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med. 2005;107: 125-35.
19. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell. 2007;131:242-56.
20. Tang W, Zeve D, Suh JM, Bosnakovski D, Kyba M, Hammer RE, Tallquist MD, GraffJM. White fat progenitor cells reside in the adipose vasculature. Science. 2008;322:583-6.
21. Rodeheffer MS, Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. Cell. 2008;135:240-9.
22. Maumus M, Peyrafitte JA, D'Angelo R, Fournier-Wirth C, Bouloumié A, Casteilla L, Sengenès C, Bourin P. Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond). 2011;35:1141-53.
23. Li H, Zimmerlin L, Marra KG, Donnenberg VS, Donnenberg AD, Rubin JP. Adipogenic potential of adipose stem cell subpopulations. Plast Reconstr Surg. 2011;128:663-72.
24. Gaiba S, França LP, França JP, Ferreira LM. Characterization of human adipose-derived stem cells. Acta Cir Bras. 2012;27:471-6.
25. Majka SM, Barak Y, Klemm DJ. Concise review: adipocyte origins: weighing the possibilities. Stem Cells. 2011;29:1034-40.
26. Lafontan M. Historical perspectives in fat cell biology: the fat cell as a model for the investigation of hormonal and metabolic pathways. Am J Physiol Cell Physiol. 2012;302:C327-59.
27. Tang QQ, Otto TC, Lane MD. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A. 2004;101:9607-11.
28. Huang H, Song TJ, Li X, Hu L, He Q, Liu M, Lane MD, Tang QQ. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A. 2009; 106:12670-5.
29. Green H, Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell. 1974;3:127-33.
30. Mandrup S, Loftus TM, MacDougald OA, Kuhajda FP, Lane MD. Obese gene expression at in vitro levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc Natl Acad Sci U S A. 1997;94:4300-5.
31. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science. 2000;289:950-3.
32. Tang QQ, Otto TC, Lane MD. Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci U S A. 2003;100: 44-9.
33. Skurk T, Hauner H. Primary culture of human adipocyte precursor cells: expansion and differentiation. Methods Mol Biol. 2012;806:215-26.
34. Entenmann G, Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol. 1996;270:C1011-6.
35. Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, Heinze E, Debatin KM, Hauner H. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 2001;25:8-15.
36. Cristancho AG, LazarMA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Molec Biol. 2011;12:722-34.
37. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4:263-73.
38. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847-53.
39. Smas CM, Sul HS. Control of adipocyte differentiation. Biochem J. 1995;309:697-710.
40. Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell. 2006;125:577-91.
41. Jonker JW, Suh JM, Atkins AR, Ahmadian M, Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, et al. PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature. 2012;485:391-4.
42. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, Abate N, Zhang BB, Bonaldo P, Chua S, Scherer PE. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009;29:1575-91.
43. Laustsen PG, Michael MD, Crute BE, Cohen SE, Ueki K, Kulkarni RN, Keller SR, Lienhard GE, Kahn CR. Lipoatrophic diabetes in Irs1 (2/2)/Irs3(2/2) double knockout mice. Genes Dev. 2002;16:3213-22.
44. Magun R, Burgering BMT, Coffer PJ, Pardasni D, Lin Y, Chabot J, Sorisky A. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology. 1996;137:3590-3.
45. Xu J, Liao K. Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem. 2004;279:35914-22.
46. Fischer-Posovszky P, Tews D, Horenburg S, Debatin KM, Wabitsch M. Differential function of Akt1 and Akt2 in human adipocytes. Mol Cell Endocrinol. 2012;358:135-43.
47. El-Chaar D, Gagnon A, Sorisky A. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phophorylation of p70 S6 kinase versus eIF4E-BP1. Int J Obes Relat Metab Disord. 2004;28:191-8.
48. Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, Wu Z, Gingras AC, Katsuma A, Elchebly M, Spiegelman BM, et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med. 2001;7:1128-32.
49. Nakae J, Kitamura T, Kitamura Y, Biggs WH, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 2003;4:119-29.
50. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science. 2004;304:1325-8.
51. Magun R, Boone DL, Tsang BK, Sorisky A. The effect of adipocyte differentiation on the capacity of 3T3-L1 cells to undergo apoptosis in response to growth factor deprivation. Int J Obes Relat Metab Disord. 1998;22:567-71.
52. Magun R, Gagnon AM, Yaraghi Z, Sorisky A. Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes. 1998;47:1948-52.
53. Feng D, Tang Y, Kwon H, Zong H, Hawkins M, Kitsis RN, Pessin JE. High-fat diet-induced adipocyte cell death occurs through a cyclophilin D intrinsic signaling pathway independent of adipose tissue inflammation. Diabetes. 2011;60:2134-43.
54. Gagnon A, Dods P, Roustan-Delatour N, Chen C-S, Sorisky A. Phosphatidylinositol- 3,4,5-trisphosphate is required for IGF-1-mediated survival of 3T3-L1 preadipocytes. Endocrinology. 2001;142:205-12.
55. Niesler CU, Urso B, Prins JB, Siddle K. IGF-1 inhibits apoptosis induced by serum withdrawal, but potentiates TNF-α-induced apoptosis, in 3T3-L1 preadipocytes. J Endocrinol. 2000;167:165-74.
56. Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O'Rahilly S, Walker NI, Cameron DP. Tumor necrosis factor-a induces apoptosis of human adipose cells. Diabetes. 1997;46:1939-44.
57. Papineau D, Gagnon A, Sorisky A. Apoptosis of human abdominal preadipocytes before and after differentiation into adipocytes in culture. Metabolism. 2003;52:987-92.
58. Fischer-Posovszky P, Keuper M, Nagel S, Hesse D, Schurmann A, Debatin KM, Strauss G, Wabitsch M. Downregulation of FLIP by cycloheximide sensitizes human fat cells to CD95-induced apoptosis. Exp Cell Res. 2011;317:2200-9.
59. Niesler CU, Siddle K, Prins JB. Human preadipocytes display a depotspecific susceptibility to apoptosis. Diabetes. 1998;47:1365-8.
60. Macotela Y, Emanuelli B, Mori MA, Gesta S, Schulz TJ, Tseng YH, Kahn CR. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes. 2012;61:1691-9.
61. Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee KK, et al. Activators of peroxisome proliferator-activated receptor g have depot-specific effects on human preadipocyte differentiation. J Clin Invest. 1997; 100:3149-53.
62. Nio Y, Zighelboim J, Berek J, Bonavida B. Cycloheximide-induced modulation of TNF-mediated cytotoxicity in sensitive and resistant ovarian tumor cells. Cancer Chemother Pharmacol. 1990;26:1-8.
63. Fischer-Posovszky P, Tornqvist H, Debatin K-M, Wabitsch M. Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology. 2004;145:1849-59.
64. Gupta S. A decision between life and death during TNF-alpha-induced signaling. J Clin Immunol. 2002;22:185-94.
65. Richon VM, Lyle RE, McGehee RE, Jr. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J Biol Chem. 1997;272:10117-24.
66. Bouloumié A, Planat VC, Devedjian JC, Valet P, Saulnier-Blache JS, Record M, Lafontan M. α2-adrenergic stimulation promotes preadipocyte proliferation. Involvement of mitogen-activated protein kinases. J Biol Chem. 1994;269:30254-9.
67. Valet P, Pages C, Jeanneton O, Daviaud D, Barbe P, Record M, Saulnier- Blache JS, Lafontan M. α2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. J Clin Invest. 1998;101:1431-8.
68. Haraguchi K, Shimura H, Kawaguchi A, Ikeda M, Endo T, Onaya T. Effects of thyrotropin on the proliferation and differentiation of cultured rat preadipocytes. Thyroid. 1999;9:613-9.
69. Hutley LJ, Herington AC, Shurety W, Cheung C, Vesey DA, Cameron DP, Prins JB. Human adipose tissue endothelial cells promote preadipocyte proliferation. Am J Physiol Endocrinol Metab. 2001;281: E1037-44.
70. Van Harmelen V, Röhrig K, Hauner H. Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism. 2004;53:632-7.
71. Considine RV, Nyce MR, Morales LM, Magosin SA, Sinha MK, Bauer TL, Rosato EL, Colberg J, Caro JF. Paracrine stimulation of preadipocyte- enriched cell cultures by mature adipocytes. Am J Physiol. 1996;270:E895-9.
72. Hua K, Deng J, Harp JB. Interleukin-4 inhibits platelet-derived growth factor-induced preadipocyte proliferation. Cytokine. 2004;25:61-7.
73. Artemenko Y, Gagnon A, Sorisky A. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes. J Cell Physiol. 2009;218:228-36.
74. Miller CW, Casimir DA, Ntambi JM. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2a. Endocrinology. 1996;137:5641-50.
75. Carrière A, Fernandez Y, Rigoulet M, Pénicaud L, Casteilla L. Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett. 2003;550:163-7.
76. Blüher M. The distinction of metabolically "healthy" from "unhealthy" obese individuals. Curr Opin Lipidol. 2010;21:38-43.
77. Constant VA, Gagnon A, Landry A, Sorisky A. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia. 2006;49:1402-11.
78. Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology. 2007;148: 868-77.
79. Lu C, Kumar PA, Fan Y, Sperling MA, Menon RK. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Endocrinology. 2010;151:2189-99.
80. Bilkovski R, Schulte DM, Oberhauser F, Mauer J, Hampel B, Gutschow C, Krone W, Laudes M. Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans. Int J Obes (Lond). 2011;35:1450-4.
81. Constant VA, Gagnon A, Yarmo M, Sorisky A. The anti-adipogenic effect of macrophage-conditioned medium depends on ERK1/2 activation. Metabolism. 2008;57:465-72.
82. Yarmo MN, Gagnon A, Sorisky A. The anti-adipogenic effect of macrophage- conditioned medium requires the IKKb/NF-kB pathway. Horm Metab Res. 2010;42:831-6.
83. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P. Stimulation of inflammatory gene expression in human preadipocytes by macrophage-conditioned medium: upregulation of IL-6 production by macrophage-derived IL- 1b. Mol Cell Endocrinol. 2012;349:239-47.
84. Yarmo MN, Landry A, Molgat AS, Gagnon A, Sorisky A. Macrophageconditioned medium inhibits differentiation-induced Rb phosphorylation in 3T3-L1 preadipocytes. Exp Cell Res. 2009;315:411-8.
85. Ide J, Gagnon A, Molgat AS, Landry A, Foster C, Sorisky A. Macrophageconditioned medium inhibits the activation of cyclin-dependent kinase 2 by adipogenic inducers in 3T3-L1 preadipocytes. J Cell Physiol. 2011;226: 2297-306.
86. Keophiphath M, Achard V, Henegar C, Rouault C, Clément K, Lacasa D. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol. 2009;23:11-24.
87. Gagnon A, Yarmo MN, Landry A, Sorisky A. Macrophages alter the differentiation- dependent decreases in fibronectin and collagen I/III protein levels in human preadipocytes. Lipids. 2012;47:873-80.
88. Spiegelman BM, Ginty CA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell. 1983;35:657-66.
89. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes. Arterioscler Thromb Vasc Biol. 2005;25:2062-8.
90. Molgat AS, Gagnon A, Sorisky A. Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner. Am J Physiol Cell Physiol. 2009;296:C757-65.
91. Molgat AS, Gagnon A, Sorisky A. Macrophage-induced preadipocyte survival depends on signaling through Akt, ERK1/2, and reactive oxygen species. Exp Cell Res. 2011;317:521-30.
92. Molgat AS, Gagnon A, Foster C, Sorisky A. The activation state of macrophages alters their ability to suppress preadipocyte apoptosis. J Endocrinol. 2012;214:21-9.
93. Maumus M, Sengenès C, Decaunes P, Zakaroff-Girard A, Bourlier V, Lafontan M, Galitzky J, Bouloumié A. Evidence of in situ proliferation of adult adipose tissue-derived progenitor cells: influence of fat mass microenvironment and growth. J Clin Endocrinol Metab. 2008;93: 4098-106.
94. Neese RA, Misell LM, Turner S, Chu A, Kim J, Cesar D, Hoh R, Antelo F, Strawford A, McCune JM, et al. Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A. 2002;99:15345-50.
95. Zaragosi LE, Wdziekonski B, Villageois P, Keophiphath M, Maumus M, Tchkonia T, Bourlier V, Mohsen-Kanson T, Ladoux A, Elabd C, et al. Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes. 2010;59:2513-21.
96. Kalupahana NS, Moustaid-Moussa N, Claycombe KJ. Immunity as a link between obesity and insulin resistance. Mol Aspects Med. 2012; 33:26-34.